Posted On: 12/22/2014 9:56:15 AM
Post# of 30067
Revenue is what will drive the AMBS stock price up in 2015. But, short of having revenue, having commitments from Pharmas that they'll use LymPro is the next best thing. That will spark things for us!
Today's news means LymPro data and LymPro sales are not too far off. After that will be Lympro revenue and after that our stock price soars!!
I think if the Lympro data is at least in the high 80s we will do real well. For RUO use that will be sufficient. For general public use once we get CLIA approval, it would be nice if we were closer to the mid 90s. But we will be tweaking Lympro as we go in 2015 and I imagine we'll get it into the mid 90s before too long.
Today's news means LymPro data and LymPro sales are not too far off. After that will be Lympro revenue and after that our stock price soars!!
I think if the Lympro data is at least in the high 80s we will do real well. For RUO use that will be sufficient. For general public use once we get CLIA approval, it would be nice if we were closer to the mid 90s. But we will be tweaking Lympro as we go in 2015 and I imagine we'll get it into the mid 90s before too long.
(0)
(0)
